466 related articles for article (PubMed ID: 35884412)
21. Treatment efficacy and safety of drug-eluting beads transarterial chemoembolization versus conventional transarterial chemoembolization in hepatocellular carcinoma patients with arterioportal fistula.
Cai L; Li H; Guo J; Zhao W; Duan Y; Hou X; Cheng L; Du H; Shao X; Diao Z; Hao Y; Zheng X; Li C; Li W
Cancer Biol Ther; 2022 Dec; 23(1):89-95. PubMed ID: 35230928
[TBL] [Abstract][Full Text] [Related]
22. Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies.
Makary MS; Khandpur U; Cloyd JM; Mumtaz K; Dowell JD
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32679897
[TBL] [Abstract][Full Text] [Related]
23. Advances in transarterial therapies for hepatocellular carcinoma: is novel technology leading to better outcomes?
de Baere T; Tselikas L; Deschamps F; Boige V; Ducreux M; Hollebecque A
Hepat Oncol; 2016 Apr; 3(2):109-118. PubMed ID: 30191032
[TBL] [Abstract][Full Text] [Related]
24. Therapy of Intermediate-Stage Hepatocellular Carcinoma: Current Evidence and Clinical Practice.
Chai NX; Chapiro J
Semin Intervent Radiol; 2020 Dec; 37(5):456-465. PubMed ID: 33328701
[TBL] [Abstract][Full Text] [Related]
25. Transarterial Therapies for Hepatocellular Carcinoma: a Comprehensive Review with Current Updates and Future Directions.
Kumar Y; Sharma P; Bhatt N; Hooda K
Asian Pac J Cancer Prev; 2016; 17(2):473-8. PubMed ID: 26925630
[TBL] [Abstract][Full Text] [Related]
26. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma.
Malagari K; Pomoni M; Kelekis A; Pomoni A; Dourakis S; Spyridopoulos T; Moschouris H; Emmanouil E; Rizos S; Kelekis D
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):541-51. PubMed ID: 19937027
[TBL] [Abstract][Full Text] [Related]
27. Role of Transcatheter Intra-arterial Therapies for Hepatocellular Carcinoma.
Paul SB; Sharma H
J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S112-21. PubMed ID: 25755602
[TBL] [Abstract][Full Text] [Related]
28. Transarterial bland versus chemoembolization for hepatocellular carcinoma: rethinking a gold standard.
Massarweh NN; Davila JA; El-Serag HB; Duan Z; Temple S; May S; Sada YH; Anaya DA
J Surg Res; 2016 Feb; 200(2):552-9. PubMed ID: 26507276
[TBL] [Abstract][Full Text] [Related]
29. Intra-arterial therapies for hepatocellular carcinoma: where do we stand?
Liapi E; Geschwind JF
Ann Surg Oncol; 2010 May; 17(5):1234-46. PubMed ID: 20405328
[TBL] [Abstract][Full Text] [Related]
30. Successful Transcatheter Arterial Radioembolization of Hepatocellular Carcinoma Via Left Internal Mammary Artery: A Case Report.
Alhussaini A; Qazi SA; AlZahrani YA
Cureus; 2022 Mar; 14(3):e22954. PubMed ID: 35411262
[TBL] [Abstract][Full Text] [Related]
31. Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Huang K; Zhou Q; Wang R; Cheng D; Ma Y
J Gastroenterol Hepatol; 2014 May; 29(5):920-5. PubMed ID: 24224722
[TBL] [Abstract][Full Text] [Related]
32. The cost-effectiveness of TheraSphere in patients with hepatocellular carcinoma who are eligible for transarterial embolization.
Manas D; Bell JK; Mealing S; Davies H; Baker H; Holmes H; Hubner RA
Eur J Surg Oncol; 2021 Feb; 47(2):401-408. PubMed ID: 32958370
[TBL] [Abstract][Full Text] [Related]
33. Chemoembolization and radioembolization.
Sangro B
Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):909-19. PubMed ID: 25260317
[TBL] [Abstract][Full Text] [Related]
34. Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting.
Karalli A; Teiler J; Haji M; Seth E; Brismar TB; Wahlin S; Axelsson R; Stål P
Scand J Gastroenterol; 2019 Jul; 54(7):905-912. PubMed ID: 31287338
[No Abstract] [Full Text] [Related]
35. Transarterial chemoembolization and yittrium-90 for liver cancer and other lesions.
Minocha J; Salem R; Lewandowski RJ
Clin Liver Dis; 2014 Nov; 18(4):877-90. PubMed ID: 25438288
[TBL] [Abstract][Full Text] [Related]
36. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.
Tsochatzis EA; Germani G; Burroughs AK
Semin Oncol; 2010 Apr; 37(2):89-93. PubMed ID: 20494700
[TBL] [Abstract][Full Text] [Related]
37. The position of transarterial chemoembolization with drug-eluting beads and yttrium-90 transarterial radioembolization in patients with hepatocellular carcinoma: Consensus statements from a Delphi-method expert panel in Turkey.
Akarca US; Akhan O; Bilgiç S; Bozkurt MF; Cantaşdemir M; Çermik TF; Çakaloğlu Y; Er Ö; Ilgıt E; Çapa Kaya G; Küçük NÖ; Numan F; Parıldar M; Türkmen C
Diagn Interv Radiol; 2021 Nov; 27(6):732-739. PubMed ID: 34792027
[TBL] [Abstract][Full Text] [Related]
38. The safety and efficacy of oxaliplatin-loaded drug-eluting beads transarterial chemoembolization for the treatment of unresectable or advanced lung cancer.
Bi Y; Li F; Ren J; Han X
Front Pharmacol; 2022; 13():1079707. PubMed ID: 36518678
[No Abstract] [Full Text] [Related]
39. Clinical management of vascular lake during transarterial chemoembolization with CalliSpheres drug-eluting beads (DEBs) for the treatment of hepatocellular carcinoma.
Kong J; Jiang X; Zhang Y; Wang W; Li Y; Shen X; Guo J; Sun H; Chen D; Chen Y; Xu L
Transl Cancer Res; 2020 Apr; 9(4):2895-2903. PubMed ID: 35117646
[TBL] [Abstract][Full Text] [Related]
40. [Survival benefit with intraarterial techniques in hepatocellular carcinoma].
Sangro B
Gastroenterol Hepatol; 2014 Jul; 37 Suppl 2():95-101. PubMed ID: 25087719
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]